Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedLocations section added listing study sites across multiple states and Ontario. Revision updated to v3.3.3.SummaryDifference2%

- Check51 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no changes to study details or user-facing functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedThe government funding status banner was removed from the page. Core study content remains unchanged.SummaryDifference0.3%

- Check72 days agoChange DetectedNo substantive updates detected between the two screenshots; the study details, eligibility criteria, and locations appear unchanged.SummaryDifference0.3%

- Check100 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating-status notice; removed mention of Medullary thyroid carcinoma under Genetic and Rare Diseases Information Center and old version v3.1.0.SummaryDifference3%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.